321 related articles for article (PubMed ID: 23273755)
1. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
[TBL] [Abstract][Full Text] [Related]
2. The relationship between serum prolactin concentration and pregnancy outcome in women with unexplained recurrent miscarriage.
Li W; Ma N; Laird SM; Ledger WL; Li TC
J Obstet Gynaecol; 2013 Apr; 33(3):285-8. PubMed ID: 23550860
[TBL] [Abstract][Full Text] [Related]
3. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
4. Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction.
Arce JC; Balen A; Platteau P; Pettersson G; Andersen AN
Reprod Biomed Online; 2011 May; 22(5):449-56. PubMed ID: 21397560
[TBL] [Abstract][Full Text] [Related]
5. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
6. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
[TBL] [Abstract][Full Text] [Related]
7. Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.
Prakash A; Laird S; Tuckerman E; Li TC; Ledger WL
Fertil Steril; 2005 Jun; 83(6):1758-63. PubMed ID: 15950648
[TBL] [Abstract][Full Text] [Related]
8. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy.
Yan J; Sripada S; Saravelos SH; Chen ZJ; Egner W; Li TC
Fertil Steril; 2012 Aug; 98(2):378-82. PubMed ID: 22624672
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage.
Saravelos SH; Yan J; Rehmani H; Li TC
Hum Reprod; 2011 Dec; 26(12):3274-9. PubMed ID: 21954281
[TBL] [Abstract][Full Text] [Related]
10. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of mid luteal progesterone concentration before luteal support in controlled ovarian hyperstimulation with intrauterine insemination.
Costello MF; Emerson S; Lukic J; Sjoblom P; Garrett D; Hughes G; Steigrad S
Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):51-6. PubMed ID: 15089869
[TBL] [Abstract][Full Text] [Related]
12. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?
Lund M; Kamper-Jørgensen M; Nielsen HS; Lidegaard Ø; Andersen AM; Christiansen OB
Obstet Gynecol; 2012 Jan; 119(1):37-43. PubMed ID: 22183209
[TBL] [Abstract][Full Text] [Related]
13. Decreased endometrial vascularity and receptivity in unexplained recurrent miscarriage patients during midluteal and early pregnancy phases.
Tan SY; Hang F; Purvarshi G; Li MQ; Meng DH; Huang LL
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):522-6. PubMed ID: 26522103
[TBL] [Abstract][Full Text] [Related]
14. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
[TBL] [Abstract][Full Text] [Related]
15. Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility.
Hansen KR; Eisenberg E; Baker V; Hill MJ; Chen S; Talken S; Diamond MP; Legro RS; Coutifaris C; Alvero R; Robinson RD; Casson P; Christman GM; Santoro N; Zhang H; Wild RA;
J Clin Endocrinol Metab; 2018 Jul; 103(7):2743-2751. PubMed ID: 29767754
[TBL] [Abstract][Full Text] [Related]
16. Fundamental role of folliculo-luteal function in recurrent miscarriage.
Siklósi GS; Bánhidy FG; Ács N
Arch Gynecol Obstet; 2012 Nov; 286(5):1299-305. PubMed ID: 22744848
[TBL] [Abstract][Full Text] [Related]
17. Is subclinical hypothyroidism associated with lower live birth rates in women who have experienced unexplained recurrent miscarriage?
van Dijk MM; Vissenberg R; Bisschop PH; Dawood F; van Wely M; Goddijn M; Farquharson RG
Reprod Biomed Online; 2016 Dec; 33(6):745-751. PubMed ID: 27720162
[TBL] [Abstract][Full Text] [Related]
18. [Study on the correlation of serum folate and red blood cell folate level with birth defects and unexplained recurrent pregnancy loss].
Jiang YL; Sun NH; Xiang Y; Li SL; Qi QW; Liu JT; Bian XM; Yang JQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):448-52. PubMed ID: 17961332
[TBL] [Abstract][Full Text] [Related]
19. Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study.
Ioannidis G; Sacks G; Reddy N; Seyani L; Margara R; Lavery S; Trew G
Hum Reprod; 2005 Mar; 20(3):741-6. PubMed ID: 15591085
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage.
Tuckerman E; Laird SM; Prakash A; Li TC
Hum Reprod; 2007 Aug; 22(8):2208-13. PubMed ID: 17656418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
